LitAlert ~~ GeneLit.com

    • Nurse-led decision coaching by specialized nurses for healthy BRCA1/2 gene mutation carriers - adaptation and pilot testing of a curriculum for nurses: a qualitative study.
    • Berger-Höger B, Vitinius F, Fischer H, Beifus K, Köberlein-Neu J, Isselhard A, Töpper M, Wiedemann R, Rhiem K, Schmutzler R, Stock S, Steckelberg A.
    • BMC Nurs. 2022 Feb 10;21(1):42. doi: 10.1186/s12912-022-00810-8.
    • Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes.
    • Yap TA, Hamilton E, Bauer T, Dumbrava EE, Jeselsohn R, Enke A, Hurley S, Lin KK, Habeck J, Giordano H, Shapiro GI.
    • JCO Precis Oncol. [2022 Feb 9];6:e2100456. doi: 10.1200/PO.21.00456.
    • Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.
    • Saad M, Mokrab Y, Halabi N, Shan J, Razali R, Kunji K, Syed N, Temanni R, Subramanian M, Ceccarelli M, Qatar Genome Programme Research Consortium, Tabrizi AR, Bedognetti D, Chouchane L.
    • Lancet Oncol. 2022 Feb 9:S1470-2045(21)00752-X. doi: 10.1016/S1470-2045(21)00752-X. Epub ahead of print.

    Commentary:

    Genetic risk of cancer: a tale of diversity from the Middle East.

    • Next Generation Sequencing is a Reliable Tool for Detecting BRCA1/2 Mutations, Including Large Genomic Rearrangements.
    • Lee JH, Ryoo NH, Ha JS, Park S, Kim KB, Hee KS, Kim DH.
    • Clin Lab. 2022 Feb 1;68(2). doi: 10.7754/Clin.Lab.2021.210609.